botleft.blogg.se

Luminous dermatology
Luminous dermatology





luminous dermatology

luminous dermatology

Gammon B., Guitart J., Intertriginous mycosis fungoides: a distinct presentation of cutaneous T cell lymphoma that may be caused by malignant T follicular helper cells. Gammon B., Gerami P., Utility of Fluorescence in situ Hybridization in Ambiguous Melanocytic Tumors. British J Dermatol 2013 Apr 168(4):906-8įathi R., Kamalpour L., Gammon B., et al., A novel treatment approach for extensive, eruptive, cutaneous squamous cell carcinomas in a patient receiving BRAF-inhibitor therapy for metastatic melanoma. Gammon B., Cotliar J., Viral infection as a trigger in flares of acute graft-versus-host disease. Guitart J., Gammon B., The Difficulties in defining Follicular T helper phenotype in Cutaneous Lymphomas. Gammon B., Traczyk T., Gerami P., Clumped perinuclear BAP1 expression is a frequent finding in sporadic epithelioid spitz tumors. Shain A, Gammon B, Mueller C, Kim J., Striated muscle hamartoma presenting as a chin cyst in a newborn. Gammon B., Longmire M., DeClerck B., Intravascular crystal deposition: an early clue to the diagnosis of type I cryoglobulinemic vasculitis. Gammon B., Robson A., Arkin L., et al., Granulomatous Cytotoxic T cell lymphoma: a potential association with immunodeficiency. Johnson RC, Kim J, Natkunam Y, Sundram U, Freud AG, Gammon B, Cascio MJ, Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm. He holds various honors, awards, and merits and has participated in dozens of peer-review publications, book chapter writings, poster and oral presentations, and lectureships.

#Luminous dermatology professional

Gammon joined the Sagis team of dermatopathologists, bringing his extensive professional experience and training as a welcomed asset. After his studies, he founded several practices, including Precision Dermatopathology, Juniper Dermatology, and Luminous Dermatology.ĭr. Gammon received an MBA from the University of California Los Angeles – Anderson School of Management in 2017. Gammon then pursued additional sub-specialty training with a dermatopathology Fellowship from Stanford University (Stanford, CA).ĭr. After earning his medical degree in 2008 from the University of Texas Southwestern in Dallas, he completed his dermatology residency training at Northwestern University in Chicago, IL, serving as Co-Chief Resident. Bryan Gammon is board certified in dermatology, dermatopathology, and micrographic dermatologic surgery by the American Board of Dermatology.







Luminous dermatology